The medication prospect “three-way” is currently being sent out on to a stage Ib/II research study.
发布者：BY ANJA HAUGE，转转请注明出处：https://robotalks.cn/novo-nordisk-obesity-candidate-moves-on-to-new-trial/
关于作者
AI agents will infiltrate consumer mass market within months, says IEEE
上一篇
5 11 月, 2025 2:18 下午
Obesity drug candidate Cagrilintid begins late-stage program at Novo Nordisk
下一篇
5 11 月, 2025 2:19 下午
相关推荐
-
Baidu Wins First License to Test Self-Driving Car in Hong Kong
Self-governing driving and artificial intelligence have actually been core tenets in Baidu’s more comprehensive aspirations to increase within the expert system market.
-
Dual-cation strategy boosts upconversion efficiency in stable oxide perovskites
Scientists at the Hefei Institutes of Physical Scientific Research of the Chinese Academy of Sciences have actually established a brand-new means to dramatically boost upconversion…
-
Exploring the Latest Trends in Gaming
The pc gaming market is altering promptly. The most up to date advancements in pc gaming, consisting of cross-platform play, AI growth, live gambling enterprise video games, enhanc…
-
Epiroc’s 2025: Uneasy lies the head that wears the Krona
Damaging money results consume right into Epiroc’s 2025 orders, profits and earnings .
-
TikTok Shop sheds bargain-bin reputation as average prices climb across categories
An evaluation by ecommerce knowledge company Appeal reveals typical costs climbing up throughout greater than a lots crucial classifications …Read More
